I stand for:

#MSHR
#MSHRs
#MSHR's
#MHR
#MHRs
#MHR's

#MHVR
#MHVRs
#MHVR's
#MHSR
#MHSRs
#MHSR's

#MSHVR
#MSHVRs
#MSHVR's
#MSHSR
#MSHSRs
#MSHSR's

Had a great time at #MHSRS with my colleagues at USARIEM presenting research on the impact of the Army's H2F program on metabolic health and interacting with so many researchers and practitioners.

Looking forward to building on this work evaluating H2F's impact on the Army

A blonde woman in glasses and a mask is in front of a scientific poster

Exhausted but grateful for the opportunity once again to meet with the #MHSRS community and learn how to improve service people's and Veterans' health together. Headed homeward with a full brain and to do list.

Humotech is on the ground at the @militaryhealth.bsky.social Research Symposium. We’re immersing ourselves in insightful discussions and collaborative sessions designed to elevate military medicine.

If you’re attending too, let’s chat!

#MHSRS #MilitaryHealth #WearableRobotics #MobilityInnovation

Cresilon to Present Groundbreaking TRAUMAGEL Study at Military Health System Research Symposium 2025 Cresilon Inc. is scheduled to present its innovative TRAUMAGEL® case study at the Military Health System Research Symposium 2025 set for August in Florida.

Cresilon to Present Groundbreaking TRAUMAGEL Study at Military Health System Research Symposium 2025 #United_States #Kissimmee,_Florida #Cresilon #TRAUMAGEL #MHSRS

Save the Date: June 25th for the AM&E Lab-Sponsored Research Webinar — Maximize MHSRS experience - Office of the Vice President for Research Join us via webinar on June 25th at 12:00 PM MT to learn more about maximizing your experience at this year's conference.

💡 Heading to #MHSRS this year?

@utah.edu’s AM&E Lab is hosting a free webinar this Wednesday to help you make the most of it.

🕐 12–1 p.m. MT
🔗 Details & registration:

ATI-1701 - Appili Therapeutics PIPELINE ATI-1701 Working with Government Agencies around the World to Address a Serious Bioterrorism Threat Appili Therapeutics Inc. is developing a best-in-class live attenuated vaccine ATI-1701 (F....

At #IDWeek2024 & #MHSRS, Appili presented data showing a single-dose of ATI-1701 provided full protection against lethal tularemia one year after vaccination—a major step in potentially safeguarding military personnel. #InfectiousDisease

$APLI $APLIF

appilitherapeutics.com/ati-1701/